SMLR — Semler Scientific Share Price
0.000.00%
Last trade - 00:00- $353.53m
- $338.62m
- $56.29m
- 76
- 69
- 82
- 90
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.53 | ||
| Price to Tang. Book | 21.94 | ||
| Price to Free Cashflow | 14.51 | ||
| Price to Sales | 6.28 | ||
| EV to EBITDA | 15.74 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 8.96% | ||
| Return on Equity | 27.04% | ||
| Operating Margin | 37.19% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 38.6 | 53.03 | 56.69 | 68.18 | 56.29 | 56.5 | n/a | 11.43% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -7.56 | +24.13 | -14.75 | +47.45 | +90.33 | -65.87 | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Semler Scientific, Inc. is engaged in developing and marketing technology products and services to healthcare providers to combat chronic diseases. The Company's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The Company delivers QuantaFlo directly to its customers. The Company also invests in bitcoin and has adopted Bitcoin as its primary treasury asset.
Directors
- Douglas Murphy-Chutorian CEO (66)
- Andrew Weinstein SVF (56)
- Daniel Conger VFN (44)
- Arthur Leibowitz IND (74)
- Daniel Messina IND (65)
- Cindy Moon IND (44)
- Wayne Pan IND (57)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 24th, 2013
- Public Since
- February 27th, 2014
- No. of Shareholders
- 8
- No. of Employees
- 79
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 9,596,486
- Address
- 2340-2348 Walsh Avenue, Suite 2344, SANTA CLARA, 95051
- Web
- https://www.semlerscientific.com/
- Phone
- +1 4086274557
- Contact
- Renae Cormier
- Auditors
- BDO USA, LLP
Upcoming Events for SMLR
Q2 2025 Semler Scientific Inc Earnings Release
Similar to SMLR
Accelerate Diagnostics
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
What is the Semler Scientific share price?
As of Today at 05:09 UTC, shares in Semler Scientific are trading at $36.84. This share price information is delayed by 15 minutes.
How has the Semler Scientific share price performed this year?
Shares in Semler Scientific last closed at $36.84 and the price had moved by +42.18% over the past 365 days. In terms of relative price strength the Semler Scientific share price has outperformed the S&P500 Index by +31.24% over the past year.
What are the analyst and broker recommendations for Semler Scientific?
The overall consensus recommendation for Semler Scientific is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Semler Scientific dividend yield?
Semler Scientific does not currently pay a dividend.
Does Semler Scientific pay a dividend?
Semler Scientific does not currently pay a dividend.
When does Semler Scientific next pay dividends?
Semler Scientific does not currently pay a dividend.
How do I buy Semler Scientific shares?
To buy shares in Semler Scientific you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Semler Scientific?
As of the previous close price of $36.84, shares in Semler Scientific had a market capitalisation of $353.53m.
Where are Semler Scientific shares listed?
Here are the trading details for Semler Scientific:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: SMLR
What kind of share is Semler Scientific?
Based on an overall assessment of its quality, value and momentum Semler Scientific is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Semler Scientific share price forecast for 2025?
The analyst consensus target price for shares in Semler Scientific is $71.00. That is 92.73% above the last closing price of $36.84.
Analysts covering Semler Scientific currently have a consensus Earnings Per Share (EPS) forecast of $1.76 for the next financial year.
Find out moreWhat is the trend in the Semler Scientific share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Semler Scientific. Over the past six months, its share price has outperformed the S&P500 Index by +41.61%.
As of the last closing price of $36.84, shares in Semler Scientific were trading -7.95% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Semler Scientific PE Ratio?
The Semler Scientific PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $36.84.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Semler Scientific?
Semler Scientific's management team is headed by:
- Douglas Murphy-Chutorian - CEO
- Andrew Weinstein - SVF
- Daniel Conger - VFN
- Arthur Leibowitz - IND
- Daniel Messina - IND
- Cindy Moon - IND
- Wayne Pan - IND